Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: A case series and systematic review

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 888-894

  Khawcharoenporn, T ^a   Apisarnthanarak, A ^a   Mundy, L M ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b LM Mundy LLC   (United States)

Author keywords

Acinetobacter baumannii; Central nervous system; Colistin; Intrathecal; Intraventricular; Meningitis; Multidrug resistant; Pandrug resistant

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; IMIPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER INFECTION; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; APACHE; ARTICLE; BRAIN VENTRICULITIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID CULTURE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MALE; MORTALITY; MULTIDRUG RESISTANCE; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEIZURE; SURVIVAL TIME; SYSTEMATIC REVIEW; THAILAND; THERAPY DELAY;

ACINETOBACTER BAUMANNII;

EID: 77954656143     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03019.x     Document Type: Article

References (28)

1. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005, 11:22-29.
2. Rodríguez Guardado A, Blanco A, Asensi V. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 2008, 61:908-913.
3. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008, 46:1254-1263.
4. Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 2005, 18:502-506.
5. Andes DR, Craig WA. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis. Infect Dis Clin North Am 1999, 13:595-618.
6. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 1970, 72:857-868.
7. Rose WE, Rybak MJ. Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy 2006, 26:1099-1110.
8. Gilad J, Carmeli Y. Treatment options for multidrug-resistant Acinetobacter species. Drugs 2008, 68:165-189.
9. Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 2006, 58:1078-1081.
10. Berlana D, Llop JM, Fort E, Badia MB, Jódar R. Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections. Am J Health Syst Pharm 2005, 62:39-47.
11. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 1999, 28:916-917.
12. Al Shirawi N, Memish ZA, Cherfan A, Al Shimemeri A. Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature. J Chemother 2006, 18:554-558.
13. Sueke H, Marsh H, Dhital A. Using intrathecal colistin for multidrug resistant shunt infection. Br J Neurosurg 2005, 19:51-52.
14. Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 2007, 40:537-540.
15. Vasen W, Desmery P, Ilutovich S, Di Martino A. Intrathecal use of colistin. J Clin Microbiol 2000, 38:3523.
16. Benifla M, Zucker G, Cohen A, Alkan M. Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E. J Antimicrob Chemother 2004, 54:290-292.
17. Kaplan SL, Patrick CC. Cefotaxime and aminoglycoside treatment of meningitis caused by Gram-negative enteric organisms. Pediatr Infect Dis J 1990, 9:810-814.
18. Bukhary Z, Mahmood W, Al-Khani A, Al-Abdely HM. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin. Saudi Med J 2005, 26:656-658.
19. Kasiakou SK, Rafailidis PI, Liaropoulos K, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect 2005, 50:348-352.
20. Thom KA, Shardell MD, Osih RB. Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points. Infect Control Hosp Epidemiol 2008, 29:1048-1053.
21. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement 2007, Wayne, PA, CLSI, M100-S17
22. Apisarnthanarak A, Pinitchai U, Thongphubeth K. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008, 47:760-767.
23. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(suppl):131-138.
24. Wang KW, Chang WN, Huang CR. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005, 12:647-650.
25. Adams MD, Goglin K, Molyneaux N. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008, 190:8053-8064.
26. Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect 2006, 12:1227-1230.
27. Jiménez-Mejías ME, Pichardo-Guerrero C, Márquez-Rivas FJ, Martín-Lozano D, Prados T, Pachón J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002, 21:212-214.
28. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006, 10:R27.